Finerenone ameliorated ventricular remodeling post myocardial infarction in rats by reducing NF-KB pathway-mediated pyroptosis
{{output}}
Myocardial infarction (MI) remains a leading cardiovascular cause of mortality in patients, primarily driven by adverse post-MI ventricular remodeling tightly linked to inflammation. Finerenone, the first non-steroidal mineralocorticoid receptor (MR) antagonis... ...
